Clinical Trials Logo

Advanced Biliary Tract Carcinoma clinical trials

View clinical trials related to Advanced Biliary Tract Carcinoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05451290 Not yet recruiting - Clinical trials for Advanced Biliary Tract Carcinoma

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

This is a phase II open-label, one-arm, multicenter study aimed to explore the efficacy and safety of perioperative (neoadjuvant and adjuvant) treatment for patients with advanced biliary tract carcinoma.